In summary, we demonstrate the first indication in ovarian cancer that DIO1 is an anti‐tumor factor in the carcinogenic process, suggesting that reduction in its expression, consistently observed in several HGSOC cell lines and human tissues, may promote tumorigenesis in this aggressive disease. This evidence concerns the gene DIO1 and neoplasm.